Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era

American Journal of Cardiology

Volumn 111, Issue 4, 2013, Pages 457-464

  Nakatani, Daisaku ^a   Sakata, Yasuhiko ^a,b   Suna, Shinichiro ^a   Usami, Masaya ^a   Matsumoto, Sen ^a   Shimizu, Masahiko ^a   Hara, Masahiko ^a   Uematsu, Masaaki ^c   Fukunami, Masatake ^d   Hamasaki, Toshimitsu ^a   Sato, Hiroshi ^e   Hori, Masatsugu ^f   Komuro, Issei ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

^d OSAKA GENERAL MEDICAL CENTER   (Japan)

^e KWANSEI GAKUIN UNIVERSITY   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS RISK SCORE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873281624     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.10.026     Document Type: Article

References (29)

1. E.M. Antman, D.T. Anbe, P.W. Armstrong, E.R. Bates, L.A. Green, M. Hand, J.S. Hochman, H.M. Krumholz, F.G. Kushner, G.A. Lamas, C.J. Mullany, J.P. Ornato, D.L. Pearle, M.A. Sloan, S.C. Smith Jr., J.S. Alpert, J.L. Anderson, D.P. Faxon, V. Fuster, R.J. Gibbons, G. Gregoratos, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, A.K. Jacobs, and J.P. Ornato ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction) J Am Coll Cardiol 44 2004 E1 E211
2. F.G. Kushner, M. Hand, S.C. Smith Jr., S.B. King III, J.L. Anderson, E.M. Antman, S.R. Bailey, E.R. Bates, J.C. Blankenship, D.E. Casey Jr., L.A. Green, J.S. Hochman, A.K. Jacobs, H.M. Krumholz, D.A. Morrison, J.P. Ornato, D.L. Pearle, E.D. Peterson, M.A. Sloan, P.L. Whitlow, and D.O. Williams 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
3. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, A. Kastrati, A. Rosengren, P.G. Steg, M. Tubaro, F. Verheugt, F. Weidinger, M. Weis, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, S. Silber, F.V. Aguirre, N. Al-Attar, E. Alegria, F. Andreotti, W. Benzer, O. Breithardt, N. Danchin, C. Di Mario, D. Dudek, D. Gulba, S. Halvorsen, P. Kaufmann, R. Kornowski, G.Y. Lip, and F. Rutten Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
4. J. Lopez-Sendon, K. Swedberg, J. McMurray, J. Tamargo, A.P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, P. Lechat, and C. Torp-Pedersen Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
5. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results JAMA 250 1983 2814 2819
6. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results JAMA 247 1982 1707 1714
7. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
8. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371
9. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
10. K.A. Fox, P.G. Steg, K.A. Eagle, S.G. Goodman, F.A. Anderson Jr., C.B. Granger, M.D. Flather, A. Budaj, A. Quill, and J.M. Gore Decline in rates of death and heart failure in acute coronary syndromes 1999-2006 JAMA 297 2007 1892 1900
11. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, T.E. Kottke, W.H. Giles, and S. Capewell Explaining the decrease in U.S. deaths from coronary disease 1980-2000 N Engl J Med 356 2007 2388 2398
12. D. Nakatani, Y. Sakata, H. Mizuno, M. Shimizu, S. Suna, M. Usami, H. Ito, Y. Yasumura, A. Hirayama, H. Takeda, M. Hori, and H. Sato Impact of diabetes mellitus on rehospitalization for heart failure among survivors of acute myocardial infarction in the percutaneous coronary intervention era Circ J 73 2009 662 666
13. K.A. Eagle, M.J. Lim, O.H. Dabbous, K.S. Pieper, R.J. Goldberg, F. Van de Werf, S.G. Goodman, C.B. Granger, P.G. Steg, J.M. Gore, A. Budaj, A. Avezum, M.D. Flather, and K.A. Fox A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733
14. D. Rubin Inference and missing data Biometrika 63 1976 581 592
15. D. Rubin Multiple Imputation for Nonresponse in Surveys 1987 John Wiley & Sons New York, New York
16. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
17. A. Wang, P. Pappas, K.J. Anstrom, E. Abrutyn, V.G. Fowler Jr, B. Hoen, J.M. Miro, G.R. Corey, L. Olaison, J.A. Stafford, C.A. Mestres, and C.H. Cabell The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort Am Heart J 150 2005 1086 1091
18. K.G. Tarakji, R. Brunken, P.M. McCarthy, M.O. Al-Chekakie, A. Abdel-Latif, C.E. Pothier, E.H. Blackstone, and M.S. Lauer Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction Circulation 113 2006 230 237
19. G. Montalescot, F. Philippe, A. Ankri, E. Vicaut, E. Bearez, J.E. Poulard, D. Carrie, D. Flammang, A. Dutoit, A. Carayon, C. Jardel, M. Chevrot, J.P. Bastard, F. Bigonzi, and D. Thomas French Investigators of the ESSENCE Trial. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin Circulation 98 1998 294 299
20. M.R. Segal Regression trees for censored data Biometrics 44 1988 35 48
21. E.M. Antman, M. Hand, P.W. Armstrong, E.R. Bates, L.A. Green, L.K. Halasyamani, J.S. Hochman, H.M. Krumholz, G.A. Lamas, C.J. Mullany, D.L. Pearle, M.A. Sloan, S.C. Smith Jr., D.T. Anbe, F.G. Kushner, J.P. Ornato, D.L. Pearle, M.A. Sloan, A.K. Jacobs, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, J.L. Halperin, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel, L.G. Tarkington, and C.W. Yancy 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
22. J. McMurray, L. Kober, M. Robertson, H. Dargie, W. Colucci, J. Lopez-Sendon, W. Remme, D.N. Sharpe, and I. Ford Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial J Am Coll Cardiol 45 2005 525 530
23. R.N. Doughty, G.A. Whalley, H.A. Walsh, G.D. Gamble, J. Lopez-Sendon, and N. Sharpe Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy Circulation 109 2004 201 206
24. K. Chadda, S. Goldstein, R. Byington, and J.D. Curb Effect of propranolol after acute myocardial infarction in patients with congestive heart failure Circulation 73 1986 503 510
25. S.S. Gottlieb, R.J. McCarter, and R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
26. L. Gordon, and R.A. Olshen Tree-structured survival analysis Cancer Treat Rep 69 1985 1065 1069
27. M.R. Segal Features of tree-structured survival analysis Epidemiology 8 1997 344 346
28. P. Tuppin, A. Neumann, N. Danchin, C. de Peretti, A. Weill, P. Ricordeau, and H. Allemand Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization Arch Cardiovasc Dis 103 2010 363 375
29. N.G. Bellenger, M.I. Burgess, S.G. Ray, A. Lahiri, A.J. Coats, J.G. Cleland, and D.J. Pennell Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 21 2000 1387 1396